 |
PDBsum entry 2c4i
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Glycoprotein
|
 |
|
Title:
|
 |
Crystal structure of engineered avidin
|
|
Structure:
|
 |
Avidin. Chain: a. Engineered: yes
|
|
Source:
|
 |
Gallus gallus. Chicken. Organism_taxid: 9031. Expressed in: escherichia coli. Expression_system_taxid: 562
|
|
Biol. unit:
|
 |
Dimer (from PDB file)
|
|
Resolution:
|
 |
|
1.95Å
|
R-factor:
|
0.200
|
R-free:
|
0.246
|
|
|
Authors:
|
 |
V.P.Hytonen,J.Horha,T.T.Airenne,E.A.Niskanen,K.Helttunen,M.S.Johnson, T.A.Salminen,M.S.Kulomaa,H.R.Nordlund
|
Key ref:
|
 |
V.P.Hytönen
et al.
(2006).
Controlling quaternary structure assembly: subunit interface engineering and crystal structure of dual chain avidin.
J Mol Biol,
359,
1352-1363.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
19-Oct-05
|
Release date:
|
05-Jul-06
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P02701
(AVID_CHICK) -
Avidin from Gallus gallus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
152 a.a.
242 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 31 residue positions (black
crosses)
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Mol Biol
359:1352-1363
(2006)
|
|
PubMed id:
|
|
|
|
|
| |
|
Controlling quaternary structure assembly: subunit interface engineering and crystal structure of dual chain avidin.
|
|
V.P.Hytönen,
J.Hörhä,
T.T.Airenne,
E.A.Niskanen,
K.J.Helttunen,
M.S.Johnson,
T.A.Salminen,
M.S.Kulomaa,
H.R.Nordlund.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Dual chain avidin (dcAvd) is an engineered avidin form, in which two circularly
permuted chicken avidin monomers are fused into one polypeptide chain. DcAvd can
theoretically form two different pseudotetrameric quaternary assemblies because
of symmetry at the monomer-monomer interfaces. Here, our aim was to control the
assembly of the quaternary structure of dcAvd. We introduced the mutation I117C
into one of the circularly permuted domains of dcAvd and scanned residues along
the 1-3 subunit interface of the other domain. Interestingly, V115H resulted in
a single, disulfide locked quaternary assembly of dcAvd, whereas I117H could not
guide the oligomerisation process even though it stabilised the protein. The
modified dcAvd forms were found to retain their characteristic pseudotetrameric
state both at high and low pH, and were shown to bind D-biotin at levels
comparable to that of wild-type chicken avidin. The crystal structure of
dcAvd-biotin complex at 1.95 Angstroms resolution demonstrates the formation of
the functional dcAvd pseudotetramer at the atomic level and reveals the
molecular basis for its special properties. Altogether, our data facilitate
further engineering of the biotechnologically valuable dcAvd scaffold and gives
insights into how to guide the quaternary structure assembly of oligomeric
proteins.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1. Possible quaternary assemblies of dcAvd. (a)
Schematic presentation of the possible quaternary structure
configurations of dcAvd pseudotetramers. Domains equal to
cpAvd5→4 and cpAvd6→5 of dcAvd are coloured red and blue,
respectively. Based on SDS-PAGE analysis (Figure 2), the
dcAvd(I117C[5→4]), dcAvd(I117C[5→4]M96H[6→5]) and
dcAvd(I117C[5→4]I117H[6→5]) mutants are a mixture of two
conformations (double-headed arrow) but the
dcAvd(I117C[5→4]V115H[6→5] mutant did form a single,
disulfide bridge locked conformation (unequal double-headed
arrow). The configuration of the quaternary structure could not
be determined for dcAvd(I117C[5→4]I117C[6→5]) mutant and for
the wt dcAvd in our experimental setup (indicated with question
mark). The quaternary assembly observed in the X-ray structure
of dcAvd is shown inside a black square and the engineered
disulfide locked assembly, dcAvd(I117C[5→4]V115H[6→5]),
inside a green square. Mutations are shown by symbols: cysteine,
bar; histidine, pentagon; isoleucine, methionine and valine,
oval. (b) View of the 1-3 subunit interface from the X-ray
structure of dcAvd illustrating the symmetry and hydrophobic
character of the interface. Colouring as in (a). The side-chains
of residues 96, 115 and 117 are shown as stick models. Both
V115 and I117 are located on strand β8, whereas M96 is located
on strand β7. Structural water molecules within 4 Å of
residues in the interface are shown as dotted spheres. The four
valine residues at position 115 (boxed) form a hydrophobic core
shielded from solvent and are positioned at the intersection of
the 1-2, 1-3 and 1-4 subunit interfaces. (c) The view is rotated
−90° around the y-axis with respect to (b). Figure 1.
Possible quaternary assemblies of dcAvd. (a) Schematic
presentation of the possible quaternary structure configurations
of dcAvd pseudotetramers. Domains equal to cpAvd5→4 and
cpAvd6→5 of dcAvd are coloured red and blue, respectively.
Based on SDS-PAGE analysis ([3]Figure 2), the
dcAvd(I117C[5→4]), dcAvd(I117C[5→4]M96H[6→5]) and
dcAvd(I117C[5→4]I117H[6→5]) mutants are a mixture of two
conformations (double-headed arrow) but the
dcAvd(I117C[5→4]V115H[6→5] mutant did form a single,
disulfide bridge locked conformation (unequal double-headed
arrow). The configuration of the quaternary structure could not
be determined for dcAvd(I117C[5→4]I117C[6→5]) mutant and for
the wt dcAvd in our experimental setup (indicated with question
mark). The quaternary assembly observed in the X-ray structure
of dcAvd is shown inside a black square and the engineered
disulfide locked assembly, dcAvd(I117C[5→4]V115H[6→5]),
inside a green square. Mutations are shown by symbols: cysteine,
bar; histidine, pentagon; isoleucine, methionine and valine,
oval. (b) View of the 1-3 subunit interface from the X-ray
structure of dcAvd illustrating the symmetry and hydrophobic
character of the interface. Colouring as in (a). The side-chains
of residues 96, 115 and 117 are shown as stick models. Both V115
and I117 are located on strand β8, whereas M96 is located on
strand β7. Structural water molecules within 4 Å of
residues in the interface are shown as dotted spheres. The four
valine residues at position 115 (boxed) form a hydrophobic core
shielded from solvent and are positioned at the intersection of
the 1-2, 1-3 and 1-4 subunit interfaces. (c) The view is rotated
−90° around the y-axis with respect to (b).
|
 |
Figure 3.
Figure 3. Stereo representations of the X-ray structure of
dcAvd. (a) The functional unit of dcAvd. The monomer of the
asymmetric unit (I) and its crystallographic symmetry mate (II)
were used to create the pseudotetramer. Domains equal to
cpAvd5→4 and cpAvd6→5 of dcAvd are coloured red and blue,
respectively. The positions of the linker regions L1-L3 (see the
text for details) are indicated (* represents L2). The
pseudosubunits 1 to 4 of the dcAvd structure are indicated by
circled numbers as described by Livnah et al. (3). The bound
biotin molecules are shown as spheres. (b) A monomer of dcAvd.
The view is rotated −90° around the y-axis with respect to
(a). Colouring and labelling as in (a). The N and C terminus of
dcAvd are indicated. (c) Superimposition of the cpAvd5→4
domain with the cpAvd6→5 domain, and with the A subunits of
two known avidin−biotin complex structures (PDB code 2AVI
(light grey) and 1AVD (grey)). The N and C termini of the native
avidin structures are labelled with an asterisk. Other labels
and colouring are as in (b). Only the biotin of cpAvd5→4 is
shown. (d) Comparison of the biotin binding modes of the
cpAvd5→4 domain, cpAvd6→5 domain, 2AVI and 1AVD structures.
The residues are labelled according to wt avidin. The label for
residue Phe72, which is in a clearly different conformation in
the cpAvd6→5 domain compared to the other shown structures, is
indicated with a yellow background. The weighted difference
F[o]−F[c] electron density map (cyan), calculated in the
absence of biotin, is drawn with a 2.2 Å radius around the
atoms of D-biotin of the final structure of the cpAvd5→4
domain. Only side-chains of amino acids are shown except for
residues 37−40 of the loop between β-strands three and four.
Figure 3. Stereo representations of the X-ray structure of
dcAvd. (a) The functional unit of dcAvd. The monomer of the
asymmetric unit (I) and its crystallographic symmetry mate (II)
were used to create the pseudotetramer. Domains equal to
cpAvd5→4 and cpAvd6→5 of dcAvd are coloured red and blue,
respectively. The positions of the linker regions L1-L3 (see the
text for details) are indicated (* represents L2). The
pseudosubunits 1 to 4 of the dcAvd structure are indicated by
circled numbers as described by Livnah et al. (3). The bound
biotin molecules are shown as spheres. (b) A monomer of dcAvd.
The view is rotated −90° around the y-axis with respect to
(a). Colouring and labelling as in (a). The N and C terminus of
dcAvd are indicated. (c) Superimposition of the cpAvd5→4
domain with the cpAvd6→5 domain, and with the A subunits of
two known avidin−biotin complex structures (PDB code 2AVI
(light grey) and 1AVD (grey)). The N and C termini of the native
avidin structures are labelled with an asterisk. Other labels
and colouring are as in (b). Only the biotin of cpAvd5→4 is
shown. (d) Comparison of the biotin binding modes of the
cpAvd5→4 domain, cpAvd6→5 domain, 2AVI and 1AVD structures.
The residues are labelled according to wt avidin. The label for
residue Phe72, which is in a clearly different conformation in
the cpAvd6→5 domain compared to the other shown structures, is
indicated with a yellow background. The weighted difference
F[o]−F[c] electron density map (cyan), calculated in the
absence of biotin, is drawn with a 2.2 Å radius around the
atoms of D-biotin of the final structure of the cpAvd5→4
domain. Only side-chains of amino acids are shown except for
residues 37−40 of the loop between β-strands three and four.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(2006,
359,
1352-1363)
copyright 2006.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
O.H.Laitinen,
H.R.Nordlund,
V.P.Hytönen,
and
M.S.Kulomaa
(2007).
Brave new (strept)avidins in biotechnology.
|
| |
Trends Biotechnol,
25,
269-277.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
');
}
}
 |